Synthesis of 3,4-dihydro-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxides and their evaluation as ligands for NMDA receptor glycine binding site

被引:3
作者
Bluke, Zanda [1 ,2 ]
Paass, Einars [2 ]
Sladek, Meik [3 ]
Abel, Ulrich [3 ]
Kauss, Valerjans [2 ]
机构
[1] Riga Tech Univ, Riga, Latvia
[2] Latvian Inst Organ Synth, Aizkraukles 21, LV-1006 Riga, Latvia
[3] Merz Pharmaceut GmbH, Frankfurt, Germany
关键词
3,4-Dihydro-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxide; glycine binding site; N-methyl-D-aspartate receptor; structure-activity relationship; D-ASPARTATE RECEPTOR; ANTAGONISTS; DERIVATIVES; BRAIN; INHIBITORS; POTENT;
D O I
10.3109/14756366.2015.1057722
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of 2-substituted 3,4-dihydro-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxides were synthesized and evaluated for their affinity to the glycine binding site of the N-methyl-D-aspartate (NMDA) receptor. The binding affinity was determined by the displacement of radioligand [H-3]MDL-105,519 from rat cortical membrane preparations. The most attractive structures in the search for prospective NMDA receptor ligands were identified to be 2-arylcarbonylmethyl substituted 3,4-dihydro-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxides. It has been demonstrated for the first time that the replacement of NH group in the ligand by sp(3) CH2 is tolerated. This finding may pave the way for previously unexplored approaches for designing new ligands of the NMDA receptor.
引用
收藏
页码:664 / 673
页数:10
相关论文
共 26 条
[1]  
Baron BM, 1996, J PHARMACOL EXP THER, V279, P62
[2]   Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist [J].
Baron, BM ;
Harrison, BL ;
Kehne, JH ;
Schmidt, CJ ;
VanGiersbergen, PLM ;
White, HS ;
Siegel, BW ;
Senyah, Y ;
McCloskey, TC ;
Fadayel, GM ;
Taylor, VL ;
Murawsky, MK ;
Nyce, P ;
Salituro, FG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 323 (2-3) :181-192
[3]   Competitive Gly/NMDA receptor antagonists [J].
Catarzi, Daniela ;
Colotta, Vittoria ;
Varano, Flavia .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (08) :809-821
[4]   Synthesis and biological evaluation of a series of quinazoline-2-carboxylic acids and quinazoline-2,4-diones as glycine-NMDA antagonists: A pharmacophore model based approach [J].
Colotta, V ;
Catarzi, D ;
Varano, F ;
Cecchi, L ;
Filacchioni, G ;
Galli, A ;
Costagli, C .
ARCHIV DER PHARMAZIE, 1997, 330 (05) :129-134
[5]   Structure-activity relationships for allosteric NMDA receptor inhibitors based on 2-naphthoic acid [J].
Costa, Blaise Mathias ;
Irvine, Mark W. ;
Fang, Guangyu ;
Eaves, Richard J. ;
Mayo-Martin, Maria Belen ;
Laube, Bodo ;
Jane, David E. ;
Monaghan, Daniel T. .
NEUROPHARMACOLOGY, 2012, 62 (04) :1730-1736
[6]   Peripherally acting NMDA receptor/glycineB Site receptor antagonists inhibit morphine tolerance [J].
Danysz, W ;
Kozela, E ;
Parsons, CG ;
Sladek, M ;
Bauer, T ;
Popik, P .
NEUROPHARMACOLOGY, 2005, 48 (03) :360-371
[7]  
Danysz W, 1998, PHARMACOL REV, V50, P597
[8]   N-(6,7-Dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-D-aspartate receptor antagonists for the treatment of pain [J].
Deur, Christopher ;
Agrawal, Arun K. ;
Baum, Heidi ;
Booth, John ;
Bove, Susan ;
Brieland, Joan ;
Bunker, Amy ;
Connolly, Cleo ;
Cornicelli, Joseph ;
Dumin, JoAnn ;
Finzel, Barry ;
Gan, Xinmin ;
Guppy, Sheila ;
Kamilar, Gregg ;
Kilgore, Kenneth ;
Lee, Pil ;
Loi, Cho-Ming ;
Lou, Zhen ;
Morris, Mark ;
Philippe, Laurence ;
Przybranowski, Sally ;
Riley, Frank ;
Samas, Brian ;
Sanchez, Brian ;
Tecle, Halle ;
Wang, Ziqiang ;
Welch, Kathryn ;
Wilson, Michael ;
Yates, Karen .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) :4599-4603
[9]   THE NOVEL ANTICONVULSANT MK-801 BINDS TO THE ACTIVATED STATE OF THE N-METHYL-D-ASPARTATE RECEPTOR IN RAT-BRAIN [J].
FOSTER, AC ;
WONG, EHF .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 91 (02) :403-409
[10]  
Henrich M, 2010, PCT Patent Appl, Patent No. [WO 2010:139481, 2010139481]